ClearPoint Neuro Q4 Sales $10.400M Beat $10.050M Estimate
3/17/2026
Impact: 75
Healthcare
ClearPoint Neuro (NASDAQ: CLPT) reported Q4 sales of $10.400 million, exceeding the analyst consensus estimate of $10.050 million by 3.48%. This represents a significant year-over-year increase of 33.83% from $7.771 million in the same quarter last year.
AI summary, not financial advice
Share: